Method for diagnosing invasive Candida infections
US9778259B2 · kind B2 · utility
0Cited by
7References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 18, 2013 |
| Grant date | Oct 3, 2017 |
| Priority date | — |
| Expiry date | Mar 18, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/56961
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention concerns an in vitro method for diagnosing invasive candidiasis (IC) in a subject which comprises detecting the presence of a Candida glycan and detecting the presence of antibody directed against a protein selected from the group consisting of fructose bisphosphate aldolase (Fba1), enolase 1 (Eno1), heat shock protein 90 (Hsp90), hyphal wall protein (Hwp1), and mannoprotein 65 (Mp65) in a blood, plasma or serum sample of the subject. The invention also relates to a method of determining a suitable treatment regimen for a patient and to a kit for implanting the methods described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.